{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:52:47Z","timestamp":1793641967964,"version":"4.5.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:00:00Z","timestamp":1733270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:00:00Z","timestamp":1733270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Fujian Provincial Clinical Research Center for Cancer Radiotherapy and Immunotherapy","award":["2020Y2012"],"award-info":[{"award-number":["2020Y2012"]}]},{"name":"Joint Funds for the innovation of science and Technology, Fujian province","award":["2021Y9218 2023Y9419"],"award-info":[{"award-number":["2021Y9218 2023Y9419"]}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"crossref","award":["2023J011296 2023J011295"],"award-info":[{"award-number":["2023J011296 2023J011295"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100017686","name":"Fujian Provincial Health Technology Project","doi-asserted-by":"publisher","award":["2023GGA054 2022GGA031"],"award-info":[{"award-number":["2023GGA054 2022GGA031"]}],"id":[{"id":"10.13039\/501100017686","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-81911-z","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T22:14:13Z","timestamp":1733264053000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Osthole induces accumulation of impaired autophagosome against pancreatic cancer cells"],"prefix":"10.1038","volume":"14","author":[{"given":"Ningna","family":"Weng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujuan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanchen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,4]]},"reference":[{"key":"81911_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"Cancer J. Clin."},{"key":"81911_CR2","first-page":"1686","volume":"71","author":"CJ Cabasag","year":"2022","unstructured":"Cabasag, C. J. et al. Pancreatic cancer: an increasing global public health concern. Gut 71, 1686\u20131687 (2022).","journal-title":"Gut"},{"key":"81911_CR3","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1001\/jama.2021.13027","volume":"326","author":"W Park","year":"2021","unstructured":"Park, W., Chawla, A. & O\u2019Reilly, E. M. Pancreatic Cancer: a review. JAMA 326, 851\u2013862 (2021).","journal-title":"JAMA"},{"key":"81911_CR4","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1053\/j.gastro.2019.01.259","volume":"156","author":"AD Singhi","year":"2019","unstructured":"Singhi, A. D., Koay, E. J., Chari, S. T. & Maitra, A. Early detection of pancreatic Cancer: opportunities and challenges. Gastroenterology 156, 2024\u20132040 (2019).","journal-title":"Gastroenterology"},{"key":"81911_CR5","doi-asserted-by":"publisher","first-page":"104740","DOI":"10.1016\/j.phrs.2020.104740","volume":"155","author":"AL Miller","year":"2020","unstructured":"Miller, A. L., Garcia, P. L. & Yoon, K. J. Developing effective combination therapy for pancreatic cancer: an overview. Pharmacol. Res. 155, 104740 (2020).","journal-title":"Pharmacol. Res."},{"key":"81911_CR6","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/s41591-019-0367-9","volume":"25","author":"CG Kinsey","year":"2019","unstructured":"Kinsey, C. G. et al. Protective autophagy elicited by RAF\u2192MEK\u2192ERK inhibition suggests a treatment strategy for RAS-driven cancers. Nat. Med. 25, 620\u2013627 (2019).","journal-title":"Nat. Med."},{"key":"81911_CR7","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.ccell.2020.08.004","volume":"38","author":"AS Bear","year":"2020","unstructured":"Bear, A. S., Vonderheide, R. H. & O\u2019Hara, M. H. Challenges and opportunities for Pancreatic Cancer Immunotherapy. Cancer Cell. 38, 788\u2013802 (2020).","journal-title":"Cancer cell."},{"key":"81911_CR8","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41580-018-0003-4","volume":"19","author":"I Dikic","year":"2018","unstructured":"Dikic, I. & Elazar, Z. Mechanism and medical implications of mammalian autophagy. Nat. Rev. Mol. Cell. Biol. 19, 349\u2013364 (2018).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"81911_CR9","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.devcel.2021.02.010","volume":"56","author":"DR Miller","year":"2021","unstructured":"Miller, D. R. & Thorburn, A. Autophagy and organelle homeostasis in cancer. Dev. Cell 56, 906\u2013918 (2021).","journal-title":"Dev. Cell."},{"key":"81911_CR10","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.jare.2022.08.018","volume":"48","author":"N Weng","year":"2023","unstructured":"Weng, N. et al. Repurposing antifungal drugs for cancer therapy. J. Adv. Res. 48, 259\u2013273 (2023).","journal-title":"J. Adv. Res."},{"key":"81911_CR11","doi-asserted-by":"publisher","first-page":"4457","DOI":"10.1158\/0008-5472.CAN-15-2887","volume":"76","author":"Q Dou","year":"2016","unstructured":"Dou, Q. et al. Ivermectin induces Cytostatic Autophagy by blocking the PAK1\/Akt Axis in breast Cancer. Cancer Res. 76, 4457\u20134469 (2016).","journal-title":"Cancer Res."},{"key":"81911_CR12","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1002\/mco2.102","volume":"2","author":"W Zhang","year":"2021","unstructured":"Zhang, W. et al. Sertaconazole provokes proapoptotic autophagy via stabilizing TRADD in nonsmall cell lung cancer cells. MedComm. 2, 821\u2013837 (2021).","journal-title":"MedComm (2020)"},{"key":"81911_CR13","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1016\/j.apsb.2022.01.018","volume":"12","author":"N Weng","year":"2022","unstructured":"Weng, N. et al. Repurposing econazole as a pharmacological autophagy inhibitor to treat pancreatic ductal adenocarcinoma. Acta Pharm. Sin B. 12, 3085\u20133102 (2022).","journal-title":"Acta Pharm. Sin B"},{"key":"81911_CR14","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1080\/15548627.2019.1598752","volume":"16","author":"J Jiang","year":"2020","unstructured":"Jiang, J. et al. Regorafenib induces lethal autophagy arrest by stabilizing PSAT1 in glioblastoma. Autophagy 16, 106\u2013122 (2020).","journal-title":"Autophagy"},{"key":"81911_CR15","doi-asserted-by":"publisher","first-page":"188592","DOI":"10.1016\/j.bbcan.2021.188592","volume":"1876","author":"Y Wang","year":"2021","unstructured":"Wang, Y. et al. The role of autophagy in pancreatic cancer progression. Biochim. Biophys. Acta Rev. Cancer. 1876, 188592 (2021).","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"81911_CR16","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/s41392-020-00313-5","volume":"5","author":"S Qin","year":"2020","unstructured":"Qin, S. et al. Emerging role of tumor cell plasticity in modifying therapeutic response. Signal. Transduct. Target. Ther. 5, 228 (2020).","journal-title":"Signal. Transduct. Target. Therapy"},{"key":"81911_CR17","doi-asserted-by":"publisher","first-page":"188749","DOI":"10.1016\/j.bbcan.2022.188749","volume":"1877","author":"S Qin","year":"2022","unstructured":"Qin, S. et al. Harnessing redox signaling to overcome therapeutic-resistant cancer dormancy. Biochim. Biophys. Acta Rev. Cancer. 1877, 188749 (2022).","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"81911_CR18","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/s41591-019-0368-8","volume":"25","author":"KL Bryant","year":"2019","unstructured":"Bryant, K. L. et al. Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer. Nat. Med. 25, 628\u2013640 (2019).","journal-title":"Nat. Med."},{"key":"81911_CR19","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1080\/14786419.2017.1300797","volume":"31","author":"Z Jelodarian","year":"2017","unstructured":"Jelodarian, Z. et al. New polyacetylenes from Echinophora Cinerea (Boiss.) Hedge et Lamond. Nat. Prod. Res. 31, 2256\u20132263 (2017).","journal-title":"Nat. Prod. Res."},{"key":"81911_CR20","doi-asserted-by":"crossref","unstructured":"Shokoohinia, Y. et al. Potential Anticancer Properties of Osthol: A Comprehensive Mechanistic Review. Nutrients.  10 (2018).","DOI":"10.3390\/nu10010036"},{"key":"81911_CR21","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1021\/np970430b","volume":"61","author":"M Resch","year":"1998","unstructured":"Resch, M., Steigel, A., Chen, Z. L. & Bauer, R. 5-Lipoxygenase and cyclooxygenase-1 inhibitory active compounds from Atractylodes Lancea. J. Nat. Prod. 61, 347\u2013350 (1998).","journal-title":"J. Nat. Prod."},{"key":"81911_CR22","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1002\/hep.510240307","volume":"24","author":"RL Huang","year":"1996","unstructured":"Huang, R. L. et al. Osthole increases glycosylation of hepatitis B surface antigen and suppresses the secretion of hepatitis B virus in vitro. Hepatology 24, 508\u2013515 (1996).","journal-title":"Hepatology"},{"key":"81911_CR23","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0014-2999(95)00812-8","volume":"298","author":"JH Guh","year":"1996","unstructured":"Guh, J. H. et al. Antiproliferative effect in rat vascular smooth muscle cells by osthole, isolated from Angelica Pubescens. Eur. J. Pharmacol. 298, 191\u2013197 (1996).","journal-title":"Eur. J. Pharmacol."},{"key":"81911_CR24","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.3109\/13880209.2014.907322","volume":"52","author":"Y Shokoohinia","year":"2014","unstructured":"Shokoohinia, Y. et al. Antiviral and cytotoxic evaluation of coumarins from Prangos Ferulacea. Pharm. Biol. 52, 1543\u20131549 (2014).","journal-title":"Pharm. Biol."},{"key":"81911_CR25","doi-asserted-by":"publisher","first-page":"3747","DOI":"10.7150\/ijbs.70679","volume":"18","author":"J Shi","year":"2022","unstructured":"Shi, J. et al. Repurposing oxiconazole against Colorectal Cancer via PRDX2-mediated autophagy arrest. Int. J. Biol. Sci. 18, 3747\u20133761 (2022).","journal-title":"Int. J. Biol. Sci."},{"key":"81911_CR26","doi-asserted-by":"publisher","first-page":"4975","DOI":"10.1038\/onc.2014.426","volume":"34","author":"Z Wang","year":"2015","unstructured":"Wang, Z. et al. Loss of ATF3 promotes akt activation and prostate cancer development in a pten knockout mouse model. Oncogene 34, 4975\u20134984 (2015).","journal-title":"Oncogene"},{"key":"81911_CR27","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","volume":"20","author":"AG Atanasov","year":"2021","unstructured":"Atanasov, A. G., Zotchev, S. B., Dirsch, V. M. & Supuran, C. T. Natural products in drug discovery: advances and opportunities. Nat. Rev. Drug Discov. 20, 200\u2013216 (2021).","journal-title":"Nat. Rev. Drug Discovery"},{"key":"81911_CR28","doi-asserted-by":"publisher","first-page":"176091","DOI":"10.1016\/j.ejphar.2023.176091","volume":"959","author":"S Huang","year":"2023","unstructured":"Huang, S. et al. Scoparone induces autophagic cell death via the PAK1\/AKT axis in colorectal cancer. Eur. J. Pharmacol. 959, 176091 (2023).","journal-title":"Eur. J. Pharmacol."},{"key":"81911_CR29","first-page":"737","volume":"40","author":"Y Che","year":"2018","unstructured":"Che, Y. et al. Osthole enhances antitumor activity and irradiation sensitivity of cervical cancer cells by suppressing ATM\/NF\u2013\u03baB signaling. Oncol. Rep. 40, 737\u2013747 (2018).","journal-title":"Oncol. Rep."},{"key":"81911_CR30","doi-asserted-by":"publisher","first-page":"8585598","DOI":"10.1155\/2022\/8585598","volume":"2022","author":"J Wang","year":"2022","unstructured":"Wang, J. et al. Osthole induces apoptosis and Caspase-3\/GSDME-Dependent pyroptosis via NQO1-Mediated ROS generation in HeLa cells. Oxid. Med. Cell. Longev. 2022, 8585598 (2022).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"81911_CR31","doi-asserted-by":"publisher","first-page":"e0193449","DOI":"10.1371\/journal.pone.0193449","volume":"13","author":"X Xu","year":"2018","unstructured":"Xu, X., Liu, X. & Zhang, Y. Osthole inhibits gastric cancer cell proliferation through regulation of PI3K\/AKT. PLoS One. 13, e0193449 (2018).","journal-title":"PLoS One"},{"key":"81911_CR32","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1038\/s41401-021-00757-7","volume":"43","author":"Y-Q Chen","year":"2022","unstructured":"Chen, Y-Q. et al. Osthole inhibits the migration and invasion of highly metastatic breast cancer cells by suppressing ITG\u03b13\/ITG\u03b25 signaling. Acta Pharmacol. Sin. 43, 1544\u20131555 (2022).","journal-title":"Acta Pharmacol. Sin"},{"key":"81911_CR33","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/s13046-018-0992-z","volume":"37","author":"X Dai","year":"2018","unstructured":"Dai, X. et al. Osthole inhibits triple negative breast cancer cells by suppressing STAT3. J. Exp. Clin. Cancer Res. CR. 37, 322 (2018).","journal-title":"J. Experimental Clin. cancer Research: CR"},{"key":"81911_CR34","doi-asserted-by":"publisher","first-page":"5061","DOI":"10.1021\/jf501047g","volume":"62","author":"YC Lin","year":"2014","unstructured":"Lin, Y. C. et al. Osthole inhibits insulin-like growth factor-1-induced epithelial to mesenchymal transition via the inhibition of PI3K\/Akt signaling pathway in human brain cancer cells. J. Agric. Food Chem. 62, 5061\u20135071 (2014).","journal-title":"J. Agric. Food Chem."},{"key":"81911_CR35","doi-asserted-by":"publisher","first-page":"21120","DOI":"10.18632\/oncotarget.4229","volume":"6","author":"YC Wen","year":"2015","unstructured":"Wen, Y. C. et al. By inhibiting snail signaling and miR-23a-3p, osthole suppresses the EMT-mediated metastatic ability in prostate cancer. Oncotarget 6, 21120\u201321136 (2015).","journal-title":"Oncotarget"},{"key":"81911_CR36","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1016\/j.ejca.2014.01.011","volume":"50","author":"D Hashimoto","year":"2014","unstructured":"Hashimoto, D. et al. Autophagy is needed for the growth of pancreatic adenocarcinoma and has a cytoprotective effect against anticancer drugs. Eur. J. Cancer. 50, 1382\u20131390 (2014).","journal-title":"Eur. J. cancer (Oxford England: 1990)"},{"key":"81911_CR37","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41416-020-01039-5","volume":"124","author":"M Piffoux","year":"2021","unstructured":"Piffoux, M., Eriau, E. & Cassier, P. A. Autophagy as a therapeutic target in pancreatic cancer. Br. J. Cancer. 124, 333\u2013344 (2021).","journal-title":"Br. J. Cancer"},{"key":"81911_CR38","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12943-015-0449-3","volume":"14","author":"M-C Yang","year":"2015","unstructured":"Yang, M-C. et al. Blockade of autophagy reduces pancreatic cancer stem cell activity and potentiates the tumoricidal effect of gemcitabine. Mol. Cancer. 14, 179 (2015).","journal-title":"Mol. Cancer"},{"key":"81911_CR39","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41586-020-2229-5","volume":"581","author":"K Yamamoto","year":"2020","unstructured":"Yamamoto, K. et al. Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I. Nature 581, 100\u2013105 (2020).","journal-title":"Nature"},{"key":"81911_CR40","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41575-020-0318-4","volume":"17","author":"J Hindson","year":"2020","unstructured":"Hindson, J. PDAC resistance to immunotherapy - a role for autophagy? Nat. Rev. Gastroenterol. Hepatol. 17, 382 (2020).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"81911_CR41","doi-asserted-by":"publisher","first-page":"4402","DOI":"10.1245\/s10434-015-4566-4","volume":"22","author":"BA Boone","year":"2015","unstructured":"Boone, B. A. et al. Safety and Biologic Response of pre-operative autophagy inhibition in combination with Gemcitabine in patients with pancreatic adenocarcinoma. Ann. Surg. Oncol. 22, 4402\u20134410 (2015).","journal-title":"Ann. Surg. Oncol."},{"key":"81911_CR42","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1158\/1078-0432.CCR-19-4042","volume":"26","author":"HJ Zeh","year":"2020","unstructured":"Zeh, H. J. et al. A randomized phase II preoperative study of Autophagy inhibition with High-Dose Hydroxychloroquine and Gemcitabine\/Nab-Paclitaxel in pancreatic Cancer patients. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 26, 3126\u20133134 (2020).","journal-title":"Clin. cancer Research: Official J. Am. Association Cancer Res."},{"key":"81911_CR43","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1001\/jamaoncol.2019.0684","volume":"5","author":"TB Karasic","year":"2019","unstructured":"Karasic, T. B. et al. Effect of Gemcitabine and nab-Paclitaxel with or without hydroxychloroquine on patients with Advanced Pancreatic Cancer: a phase 2 Randomized Clinical Trial. JAMA Oncol. 5, 993\u2013998 (2019).","journal-title":"JAMA Oncol."},{"key":"81911_CR44","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1186\/s13046-019-1355-0","volume":"38","author":"J Yan","year":"2019","unstructured":"Yan, J. et al. Tubeimoside-I sensitizes colorectal cancer cells to chemotherapy by inducing ROS-mediated impaired autophagolysosomes accumulation. J. Exp. Clin. cancer Res. CR. 38, 353 (2019).","journal-title":"J. Experimental Clin. cancer Research: CR"},{"key":"81911_CR45","doi-asserted-by":"publisher","first-page":"172990","DOI":"10.1016\/j.ejphar.2020.172990","volume":"874","author":"J Liang","year":"2020","unstructured":"Liang, J. et al. Osthole inhibits ovarian carcinoma cells through LC3-mediated autophagy and GSDME-dependent pyroptosis except for apoptosis. Eur. J. Pharmacol. 874, 172990 (2020).","journal-title":"Eur. J. Pharmacol."},{"key":"81911_CR46","first-page":"501","volume":"43","author":"XY Sun","year":"2021","unstructured":"Sun, X. Y. & Liu, X. [Effects of Osthole on apoptosis and autophagy of human Tongue Cancer Tca8113 cells]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao Acta Acad. Med. Sin. 43, 501\u2013506 (2021).","journal-title":"Zhongguo Yi Xue Ke Xue yuan xue bao Acta Academiae Medicinae Sinicae"},{"key":"81911_CR47","doi-asserted-by":"publisher","first-page":"726","DOI":"10.3892\/ol.2021.12987","volume":"22","author":"XH Zhou","year":"2021","unstructured":"Zhou, X. H., Kang, J., Zhong, Z. D. & Cheng, Y. Osthole induces apoptosis of the HT-29 cells via endoplasmic reticulum stress and autophagy. Oncol. Lett. 22, 726 (2021).","journal-title":"Oncol. Lett."},{"key":"81911_CR48","doi-asserted-by":"publisher","first-page":"155383","DOI":"10.1016\/j.phymed.2024.155383","volume":"125","author":"J Song","year":"2024","unstructured":"Song, J. et al. Osthole impairs mitochondrial metabolism and the autophagic flux in colorectal cancer. Phytomedicine: Int. J. Phytother. Phytopharmacol. 125, 155383 (2024).","journal-title":"Phytomedicine: Int. J. Phytotherapy Phytopharmacology"},{"key":"81911_CR49","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s00253-019-10257-8","volume":"104","author":"Z Xu","year":"2020","unstructured":"Xu, Z. et al. Targeting PI3K\/AKT\/mTOR-mediated autophagy for tumor therapy. Appl. Microbiol. Biotechnol. 104, 575\u2013587 (2020).","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"81911_CR50","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.biopha.2018.03.106","volume":"102","author":"X Zhu","year":"2018","unstructured":"Zhu, X. et al. Osthole inhibits the PI3K\/AKT signaling pathway via activation of PTEN and induces cell cycle arrest and apoptosis in esophageal squamous cell carcinoma. Biomed. Pharmacother. 102, 502\u2013509 (2018).","journal-title":"Biomed. Pharmacother"},{"key":"81911_CR51","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1756-9966-30-33","volume":"30","author":"X Xu","year":"2011","unstructured":"Xu, X. et al. Osthole induces G2\/M arrest and apoptosis in lung cancer A549 cells by modulating PI3K\/Akt pathway. J. Exp. Clin. Cancer Research CR. 30, 33 (2011).","journal-title":"J. Experimental Clin. cancer Research: CR"},{"key":"81911_CR52","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.3892\/ijmm.2017.3113","volume":"40","author":"X Zhu","year":"2017","unstructured":"Zhu, X. et al. Osthole induces apoptosis and suppresses proliferation via the PI3K\/Akt pathway in intrahepatic cholangiocarcinoma. Int. J. Mol. Med. 40, 1143\u20131151 (2017).","journal-title":"Int. J. Mol. Med."},{"key":"81911_CR53","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.canlet.2013.05.022","volume":"337","author":"Y Liu","year":"2013","unstructured":"Liu, Y. et al. Induction of DNA damage and ATF3 by retigeric acid B, a novel topoisomerase II inhibitor, promotes apoptosis in prostate cancer cells. Cancer Lett. 337, 66\u201376 (2013).","journal-title":"Cancer Lett."},{"key":"81911_CR54","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s13046-018-0919-8","volume":"37","author":"C Chen","year":"2018","unstructured":"Chen, C. et al. ATF3 inhibits the tumorigenesis and progression of hepatocellular carcinoma cells via upregulation of CYR61 expression. J. Exp. Clin. Cancer Res. CR. 37, 263 (2018).","journal-title":"J. Experimental Clin. cancer Research: CR"},{"key":"81911_CR55","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/onc.2017.310","volume":"37","author":"Z Wang","year":"2018","unstructured":"Wang, Z. et al. Atf3 deficiency promotes genome instability and spontaneous tumorigenesis in mice. Oncogene 37, 18\u201327 (2018).","journal-title":"Oncogene"},{"key":"81911_CR56","doi-asserted-by":"publisher","first-page":"11983","DOI":"10.1158\/0008-5472.CAN-06-0943","volume":"66","author":"S Bandyopadhyay","year":"2006","unstructured":"Bandyopadhyay, S. et al. The tumor metastasis suppressor gene Drg-1 down-regulates the expression of activating transcription factor 3 in prostate cancer. Cancer Res. 66, 11983\u201311990 (2006).","journal-title":"Cancer Res."},{"key":"81911_CR57","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/1471-2407-8-268","volume":"8","author":"A Wang","year":"2008","unstructured":"Wang, A. et al. The transcription factor ATF3 acts as an oncogene in mouse mammary tumorigenesis. BMC Cancer. 8, 268 (2008).","journal-title":"BMC cancer"},{"key":"81911_CR58","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/1759-7714.12421","volume":"8","author":"X Li","year":"2017","unstructured":"Li, X. et al. Activating transcription factor 3 promotes malignance of lung cancer cells in vitro. Thorac. Cancer. 8, 181\u2013191 (2017).","journal-title":"Thorac. Cancer"},{"key":"81911_CR59","doi-asserted-by":"publisher","first-page":"121331","DOI":"10.1016\/j.lfs.2022.121331","volume":"315","author":"B Zhu","year":"2023","unstructured":"Zhu, B. et al. Formononetin ameliorates ferroptosis-associated fibrosis in renal tubular epithelial cells and in mice with chronic kidney disease by suppressing the Smad3\/ATF3\/SLC7A11 signaling. Life Sci. 315, 121331 (2023).","journal-title":"Life Sci."},{"key":"81911_CR60","doi-asserted-by":"publisher","first-page":"4857","DOI":"10.1128\/MCB.00797-13","volume":"33","author":"S Zheng","year":"2013","unstructured":"Zheng, S. & Abraham, C. NF-\u03baB1 inhibits NOD2-induced cytokine secretion through ATF3-dependent mechanisms. Mol. Cell. Biol. 33, 4857\u20134871 (2013).","journal-title":"Mol. Cell. Biol."},{"key":"81911_CR61","doi-asserted-by":"publisher","first-page":"26908","DOI":"10.1074\/jbc.M110.132597","volume":"285","author":"P Mo","year":"2010","unstructured":"Mo, P. et al. MDM2 mediates ubiquitination and degradation of activating transcription factor 3. J. Biol. Chem. 285, 26908\u201326915 (2010).","journal-title":"J. Biol. Chem."}],"updated-by":[{"DOI":"10.1038\/s41598-025-97328-1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000}},{"DOI":"10.1038\/s41598-026-42597-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81911-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81911-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81911-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T15:04:33Z","timestamp":1773068673000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81911-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,4]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["81911"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-81911-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,4]]},"assertion":[{"value":"14 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-026-42597-7","URL":"https:\/\/doi.org\/10.1038\/s41598-026-42597-7","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":9,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":10,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-025-97328-1","URL":"https:\/\/doi.org\/10.1038\/s41598-025-97328-1","order":12,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30163"}}